Bank of Jackson Hole Trust Sells 327 Shares of CVS Health Corporation $CVS

Bank of Jackson Hole Trust trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 12.9% in the second quarter, Holdings Channel.com reports. The firm owned 2,217 shares of the pharmacy operator’s stock after selling 327 shares during the quarter. Bank of Jackson Hole Trust’s holdings in CVS Health were worth $153,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Avion Wealth increased its stake in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in CVS Health during the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc increased its stake in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC increased its stake in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares in the last quarter. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Down 1.7%

NYSE CVS opened at $80.80 on Thursday. The company has a market cap of $102.48 billion, a PE ratio of 22.57, a PEG ratio of 0.91 and a beta of 0.60. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The stock has a 50 day moving average of $76.25 and a 200-day moving average of $68.92.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the prior year, the business earned $1.09 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CVS shares. UBS Group upped their price target on CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Wolfe Research upped their price target on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research report on Monday, September 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $78.00 price target on shares of CVS Health in a research report on Tuesday, August 26th. Finally, Sanford C. Bernstein upped their price target on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $83.38.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.